{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "exchange": "LSE", "shortName": "RENEURON GROUP PLC ORD 1P", "longName": "ReNeuron Group plc", "messageBoardId": "finmb_125064", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "fullExchangeName": "LSE", "financialCurrency": "GBP", "regularMarketOpen": 7.61, "averageDailyVolume3Month": 122667, "averageDailyVolume10Day": 114115, "fiftyTwoWeekLowChange": 0.2249999, "fiftyTwoWeekLowChangePercent": 0.02990032, "fiftyTwoWeekRange": "7.525 - 39.0", "fiftyTwoWeekHighChange": -31.25, "fiftyTwoWeekHighChangePercent": -0.80128205, "fiftyTwoWeekLow": 7.525, "fiftyTwoWeekHigh": 39.0, "earningsTimestamp": 1669964410, "earningsTimestampStart": 1688369400, "earningsTimestampEnd": 1688715000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.13, "epsForward": -14.37, "epsCurrentYear": -13.33, "priceEpsCurrentYear": -0.5813953, "sharesOutstanding": 57173800, "bookValue": 0.124, "fiftyDayAverage": 9.204, "fiftyDayAverageChange": -1.4540005, "fiftyDayAverageChangePercent": -0.15797484, "twoHundredDayAverage": 17.243626, "twoHundredDayAverageChange": -9.493626, "twoHundredDayAverageChangePercent": -0.55055857, "marketCap": 4430969, "forwardPE": -0.00539318, "priceToBook": 62.5, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.0 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 7.75, "marketState": "POSTPOST", "firstTradeDateMilliseconds": 1123830000000, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1683904771, "regularMarketDayHigh": 7.825, "regularMarketDayRange": "7.525 - 7.825", "regularMarketDayLow": 7.525, "regularMarketVolume": 80594, "regularMarketPreviousClose": 7.75, "bid": 7.5, "ask": 8.0, "bidSize": 0, "askSize": 0, "symbol": "RENE.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Pencoed Business Park", "city": "Pencoed", "zip": "CF35 5HY", "country": "United Kingdom", "phone": "44 20 3819 8400", "website": "https://www.reneuron.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D", "age": 68, "title": "Exec. Chairman", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": {"raw": 137299, "fmt": "137.3k", "longFmt": "137,299"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 29500, "fmt": "29.5k", "longFmt": "29,500"}}, {"maxAge": 1, "name": "Dr. John David Sinden B.A., BA, M.A., MA, Ph.D.", "age": 71, "title": "Co-Founder", "yearBorn": 1951, "fiscalYear": 2002, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John Michael Hawkins A.C.A.", "age": 56, "title": "CFO & Director", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Suzanne  Hancock", "title": "Chief Operations Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Randolph  Corteling Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Simon  Dew", "title": "Chief Bus. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}